PATENTSCOPE: EN_ALL:nmr AND PA:teva

SALTS AND SOLID STATE FORMS OF OZANIMOD (Fri, 17 May 2019)
Disclosed are Ozanimod solid state forms, salts including hydrochloride and solid state thereof, processes for preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.
>> Read More

SALTS AND SOLID STATE FORMS OF LAROTRECTINIB (Fri, 10 May 2019)
Salts and solid state forms of Larotrectinib, processes for preparation thereof, pharmaceutical compositions thereof, and uses thereof are disclosed.
>> Read More

NEW SALT AND SOLID STATE FORMS OF ESCITALOPRAM (Fri, 19 Apr 2019)
The present disclosure relates to a new salt of escitalopram and its solid state forms, processes for the preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.
>> Read More

SOLID STATE FORMS OF ELTROMBOPAG CHOLINE (Fri, 12 Apr 2019)
Solid state forms of Eltrombopag choline, processes for preparation thereof and pharmaceutical compositions thereof are disclosed.
>> Read More

NEW CRYSTALLINE POLYMORPH OF PONESIMOD (Fri, 29 Mar 2019)
The present disclosure encompasses crystalline polymorphs of Ponesimod, processes for preparation thereof, and pharmaceutical compositions thereof.
>> Read More

RIBOCICLIB SALTS AND SOLID STATE FORMS THEREOF (Fri, 01 Mar 2019)
The present disclosure relates to Ribociclib solid state forms, Ribociclib salts including Ribociclib succinate and solid state forms thereof, as well as processes for preparation thereof and pharmaceutical compositions thereof.
>> Read More

PROCESSES FOR THE PREPARATION OF NIRAPARIB AND INTERMEDIATES THEREOF (Fri, 22 Feb 2019)
The present invention relates to novel procedures and novel intermediates useful in the synthesis of Niraparib or any salt thereof.
>> Read More

SALTS AND SOLID STATE FORMS OF PLINABULIN (Fri, 08 Feb 2019)
The present disclosure relates to Plinabulin solid state forms, Plinabulin salts including hydrochloride and solid state forms thereof, processes for preparation thereof and pharmaceutical compositions thereof.
>> Read More

IMPROVED PROCESSES FOR THE PREPARATION OF GUADECITABINE AND INTERMEDIATES THEREOF (Fri, 18 Jan 2019)
Described are procedures and intermediates for the preparation of guadecitabine, and guadecitabine salts and solid state forms thereof.
>> Read More

NEW CRYSTALLINE POLYMORPHS OF BARDOXOLONE METHYL (Fri, 18 Jan 2019)
Disclosed are crystalline polymorphs of Bardoxolone methyl, and pharmaceutical compositions thereof.
>> Read More

SOLID STATE FORMS OF MIDOSTAURIN (Fri, 14 Sep 2018)
The present disclosure relates to solid state forms of Midostaurin, processes for preparation thereof, pharmaceutical compositions thereof, and use thereof in the treatment of Acute Myelogenous Leukemia (AML) and Aggressive Systemic Mastocytosis. Chemical formula: C35H30N4O4 Molecular mass: 570.64 g/mol
>> Read More

SOLID STATE FORMS OF RUCAPARIB AND OF RUCAPARIB SALTS (Fri, 03 Aug 2018)
Disclosed are solid state forms of Rucaparib and of Rucaparib salts, and pharmaceutical compositions thereof.
>> Read More

SOLID STATE FORMS OF SOTAGLIFLOZIN (Fri, 13 Apr 2018)
Disclosed are solid state forms of Sotagliflozin, processes for preparation thereof, and pharmaceutical compositions thereof.
>> Read More

SOLID STATE FORMS OF VALBENAZINE (Fri, 13 Apr 2018)
Solid state forms of Valbenazine, Valbenazine salts, processes for preparation thereof and pharmaceutical compositions thereof are disclosed. Processes for the preparation of Valbenazine and intermediates in the preparation thereof are further described.
>> Read More

SOLID STATE FORMS OF LUMATEPERONE DITOSYLATE SALT (Fri, 16 Feb 2018)
Disclosed are solid state forms of lumateperone ditosylate, uses thereof, and pharmaceutical compositions thereof.
>> Read More

CRYSTALLINE FORM VI OF SELEXIPAG (Fri, 02 Feb 2018)
The present disclosure relates to solid state forms of Selexipag, processes for preparation thereof and pharmaceutical compositions thereof.
>> Read More

SOLID STATE FORMS OF CRISABOROLE (Fri, 19 Jan 2018)
Solid state forms of Crisaborole and salts thereof, processes for preparation thereof and pharmaceutical compositions thereof are disclosed.
>> Read More

SOLID STATE FORMS OF PALBOCICLIB DIMESYLATE (Fri, 12 Jan 2018)
Solid state forms of Palbociclib dimesylate, processes for preparation thereof and use thereof for preparation of Palbociclib are disclosed.
>> Read More

SOLID STATE FORMS OF NERATINIB AND SALTS THEREOF (Fri, 05 Jan 2018)
Solid state forms of Neratinib and salts thereof, processes for preparation thereof and pharmaceutical compositions thereof are disclosed.
>> Read More

SOLID STATE FORMS OF IXAZOMIB CITRATE (Fri, 29 Dec 2017)
The present disclosure encompasses solid state forms of Ixazomib Citrate and pharmaceutical compositions thereof. Also disclosed are processes for preparation of Ixazomib Citrate.
>> Read More